4basebio PLC
4BB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£12,333 | -£7,665 | -£5,150 | -£3,235 |
| Dep. & Amort. | £933 | £709 | £431 | £320 |
| Deferred Tax | £0 | £0 | -£128 | -£80 |
| Stock-Based Comp. | £0 | £0 | £128 | £80 |
| Change in WC | £623 | £384 | £168 | £455 |
| Other Non-Cash | £33 | £394 | -£153 | -£280 |
| Operating Cash Flow | -£10,744 | -£6,178 | -£4,704 | -£2,740 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£697 | -£871 | -£1,941 | -£1,512 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£874 | -£619 | £0 | £0 |
| Investing Cash Flow | -£1,571 | -£1,490 | -£1,941 | -£1,512 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £4,812 | £6,584 | £1,412 | -£331 |
| Stock Issued | £39,184 | £2 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£129 | -£161 | -£168 | -£136 |
| Financing Cash Flow | £43,867 | £6,425 | £1,244 | -£467 |
| Forex Effect | -£17 | -£39 | £166 | -£696 |
| Net Chg. in Cash | £31,535 | -£1,282 | -£5,235 | -£5,415 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £3,069 | £4,351 | £9,586 | £15,001 |
| End Cash | £34,604 | £3,069 | £4,351 | £9,586 |
| Free Cash Flow | -£12,315 | -£7,668 | -£6,645 | -£4,252 |